Alfieri Michael

Alfieri Michael is listed in filings as Principal Financial Officer at Aldeyra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 19, 2026, including purchase activity. Recent filings connect the profile to Aldeyra Therapeutics, Inc. (ALDX). The current snapshot covers public activity from Aug 15, 2025 to Mar 19, 2026. Reported amounts are shown as $7.1K to $13.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.